MyCancerJourney empowers patients with actionable information to improve the patient experience and outcomes in cancer treatment.
“I have seen a lot of analytical and AI healthcare solutions but MyCancerJourney is one of the very few solutions that lives up to the hype,” says OptiMed CEO Andy Reeves.
AUSTIN, TEXAS (PRWEB) OCTOBER 22, 2018
PotentiaMetrics, an Austin, Texas, based healthcare data and artificial intelligence company, announced it has partnered with OptiMed Specialty Pharmacy to launch MyCancerJourney, a shared decision-making platform for cancer treatments.
MyCancerJourney was developed by researchers at Washington University School of Medicine in St. Louis to provide patient-specific survival estimates and improve cancer patient outcomes.
OptiMed’s clients will be able to enhance the value of their oncology care by offering this personalized medical information platform for their patients. Patients will have the ability to make better decisions with their healthcare providers and have a better experience with their cancer treatment journey.
“We’re excited to include this innovative platform (MyCancerJourney) to our arsenal of tools used to improve patient outcomes and add value to the healthcare ecosystem. I have seen a lot of analytical and AI healthcare solutions but MyCancerJourney is one of the very few solutions that lives up to the hype,” says OptiMed CEO Andy Reeves.
“We are thrilled to work alongside OptiMed. Both of our companies are focused on personalized approaches to healthcare that lead to improved outcomes and better value. Together we will provide the personalized information to patients and address the high-cost of cancer treatment in a meaningful way,” says Robert Palmer, CEO of PotentiaMetrics.
PotentiaMetrics develops unique outcomes and insights solutions to support more informed, value-based treatment decisions that lead to better outcomes and reduced costs.
About OptiMed Specialty Pharmacy
OptiMed Specialty Pharmacy, based in Kalamazoo, Michigan; is dually accredited by the Accreditation Commission for Health Care (ACHC) and URAC, specializes in treatments for rare and chronic conditions, such as rheumatoid arthritis, psoriasis, multiple sclerosis, oncology, and more. The organization has decades of experience offering personalized solutions that bring meaningful value to stakeholders.
To learn more about OptiMed Specialty Pharmacy, visit: http://www.optimedspecialtyrx.com